Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
97.59
(
0.89%
)
Bitcoin
78,358.00
(
0.15%
)
News Focus
News Focus
Post# of 447439
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Tatsumaki

Send PM Follow Ignore
Followers 12
Posts 1005
Boards Moderated 0
Alias Born 09/11/2017

Tatsumaki

Re: JRoon71 post# 416069

Friday, 09/29/2023 1:32:03 PM

Friday, September 29, 2023 1:32:03 PM

Post# of 447439

And also, this requires trials, FDA approval, etc. to use this as an indication. As an adjunct to cancer treatment, this is years away, if ever.



Nobody's spending the hundreds of millions of $ needed to approve a new indication for a drug with no exclusivity.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News